Skip to main content
. 2013 Apr 4;92(4):632–636. doi: 10.1016/j.ajhg.2013.03.012

Table 1.

Clinical Presentation and SLC35A2 Mutations Identified in Three Families with CDG Type IIx

CDG-341 CDG-348 CDG-352
Ancestry European European European
Gender Male Female Male
Current Age 3 years 3 years 6 years
Inheritance de novo de novo de novo
Nucleotide Change chrX:
48,768,775_48,768,899
delinsT
chrX:
48,768,911
C>T
chrX:
48,762,195
C>T
cDNA Change c.15_91+48 delinsA c.3G>A c.991G>A
Protein Change p.Gly8Serfs9 p.Met1? p.Val331Ile
Likely Affect on Protein Termination Loss of initiator methionine Improper positioning in membrane
Developmental Delay Yes Yes Yes
Hypotonia Yes Yes Yes
Seizures Yes Yes No
Hypsarrhythmia Yes Yes No
Hypertension No No Yes
Dysmorphic features No Yes Yes
Skeletal abnormalities No Shortened extremities Shortened extremities
Renal No No Acute nephrotic syndrome; requiring dialysis
Ocular Nystagmus Retinitis pigmentosa Ocular flutter
Liver dysfunction No No No
Coagulopathy Yes No No
Gastrointestinal No Strictly G-tube feed Gastro-esophageal reflux, esophagitis, duodenal perforation
Recurrent Infections No Yes No
Microcephaly No Yes Yes
Brain malformation Small cerebellum Thinning of corpus callosum with delayed myelinization Cerebral hypoplasia/atrophy